An investigation into ovarian cancer revealed that the absence of FABP4 is linked to the metastasis of ovarian cancer, and targeting FABP4 in ovarian cancer cells can impede their capacity to adapt and colonize lipid-rich tumor microenvironments [55]. Here, FABP4 is linked to neoplasm.